the delay between referral and first specialist review for patients in each of the three referral groups. No patients referred via their (GP) were seen within the 7 days target. The differences in the proportions of patients seen between the e-mail referral group and GP referral group within 2 weeks (p = 0.0014) and within 3 weeks (p < 0.0001) were statistically significant (chi-squared test).
Overall 28.6% of patients referred were found to have nAMD in at least one eye. Figure 2 shows the delay between referral and specialist review for those patients found to have nAMD and those with other diagnoses. It shows that many patients who are subsequently confirmed to have nAMD are facing delays in accessing specialist review.
This work shows that, while there are other challenges in seeing patients in a timely manner, the use of a dedicated email referral system for nAMD can significantly reduce delays in patients being seen in specialist macular clinics compared to traditional GP-centred referral systems, and the importance of reinforcing the use of this system by optometrists and other providers of primary ophthalmic services in the community. It also highlights the need for more training of community optometrists to ensure that the rapid access pathway is used only for nAMD. 
